A Prevalence and Incidence Study Burden of Atrial and Ventricular Arrhythmias in Patients with Sleep Apnea and Hypertrophic Cardiomyopathy


About this study

The purpose of this study is to determine prevalence of sleep apnea in patients with hypertrophic cardiomyopathy and the risk of atrial and ventricular arrhythmias.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults age > 18 years old.
  • Adults with a diagnosis of HCM.
  • Both sexes.
  • Able to consent.
  • Non-pregnant.
  • Healthy controls free of hypertrophic cardiomyopathy and without a definitive family history of hypertrophic cardiomyopathy.

Exclusion Criteria:

  • Decompensated heart failure at time of enrollment (prior history of HF is not an exclusion criteria).
  • Severe (known) COPD (FEV1 between 30 and 50 percent of normal).
  • Vulnerable study populations except for minorities (minorities may be targeted to achieve 25% minority recruitment required by the NIH).
  • Pregnant women.
  • Children.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Virend Somers, M.D., Ph.D.

Open for enrollment

Contact information:

CPL HCM Sleep Study


More information


Publications are currently not available